An omentum-inspired 3D PEG hydrogel for identifying ECM-drivers of drug resistant ovarian cancer
Open accessPublished version of a preprint
The DOI matches its Crossref record; 54 of the 54 references it cites were found in a registry or an index.
Abstract
Ovarian cancer (OvCa) is a challenging disease to treat due to poor screening techniques and late diagnosis. There is an urgent need for additional therapy options, as patients recur in 70% of cases. The limited availability of clinical treatment options could be a result of poor predictions in early stage drug screens on standard tissue culture polystyrene (TCPS). TCPS does not capture the mechanical and biochemical cues that cells experience in vivo, which can impact how cells will respond to a drug. Therefore, an in vitro model that captures some of the microenvironment features that the cells experience in vivo could provide better insights into drug responses. In this study, we formed 3D multicellular tumor spheroids (MCTS) in microwells and encapsulated them in 3D omentum-inspired hydrogels. SKOV-3 MCTS were resistant to Paclitaxel in our 3D hydrogels compared to a monolayer on TCPS. Toward clinical application, we tested cells from patients [ovarian carcinoma ascites spheroids (OCAS)] who had been treated with Paclitaxel, and drug responses predicted by using the 3D omentum-inspired hydrogels demonstrated the lack of the Paclitaxel response of these samples. Additionally, we observed the presence of collagen production around the encapsulated SKOV-3 MCTS, but not significantly on TCPS. Our results demonstrated that our 3D omentum-inspired hydrogel is an improved in vitro drug testing platform to study the OvCa drug response for patient-derived cells and helped us identify collagen 3 as a potential driver of Paclitaxel resistance in 3D.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures




Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In addition, up to 75% of patients who initially respond to therapy, relapse and effective second line treatment therapies are lacking (Harries and Kaye, 2001; Cooke and Brenton, 2011; Brooks et al., 2019).”
From Microphysiological systems as models for immunologically ‘cold’ tumors (2024) · cites this paper as Brooks et al., 2019
Experimental — accuracy not yet measuredIn the citing paper
“A 4-arm PEG-maleimide based hydrogel was designed to recreate the omentum ECM with GFOGER (collagen-I), PHSRN-RGD (fibronectin), RGD (fibronectin, vitronectin, collagen-VI), and DGEA (collagen-IV) biofunctionalization peptide motifs, adjusting stiffness to a physiological level of ∼2.9 kPa for omental tissue and incorporating MMP-degradable crosslinkers (Brooks et al., 2019).”
From Three-dimensional modelling of ovarian cancer: from cell lines to organoids for discovery and personalized medicine (2022) · cites this paper as Brooks et al., 2019
In the citing paper
“This hydrogel supported cell growth and viability of SK-OV-3 multicellular spheroids that were pre-made in non-adherent polydimethylsiloxane (PDMS)-coated grids and spheroids from patient-derived ascites, with paclitaxel and doxorubicin treatments mimicking the drug responses seen in patients.”
From Three-dimensional modelling of ovarian cancer: from cell lines to organoids for discovery and personalized medicine (2022) · cites this paper as Brooks et al., 2019
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Siegel, R. L., Miller, K. D., & Jemal, A. (2018) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21442 · Cited by 16,579
Hydrogels as extracellular matrix mimics for 3D cell culture
Tibbitt, M. W., & Anseth, K. S. (2009) · Biotechnology and Bioengineering · doi:10.1002/bit.22361 · Cited by 2,727
Edmondson, R., Broglie, J. J., Adcock, A. F., & Yang, L. (2014) · ASSAY and Drug Development Technologies · doi:10.1089/adt.2014.573 · Cited by 2,515
Deconstructing the third dimension – how 3D culture microenvironments alter cellular cues
Baker, B. M., & Chen, C. S. (2012) · Journal of Cell Science · doi:10.1242/jcs.079509 · Cited by 1,760
Ovarian Cancer Development and Metastasis
Lengyel, E. (2010) · The American Journal of Pathology · doi:10.2353/ajpath.2010.100105 · Cited by 1,672
Whole–genome characterization of chemoresistant ovarian cancer
Patch, A.-M., Christie, E. L., Etemadmoghadam, D., Garsed, D. W., George, J., Fereday, S., Nones, K., Cowin, P., Alsop, K., Bailey, P. J., et al. (2015) · Nature · doi:10.1038/nature14410 · Cited by 1,569
Three-dimensional in vitro cell culture models in drug discovery and drug repositioning
Langhans, S. A. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.00006 · Cited by 1,522
Lutolf, M. P., Lauer-Fields, J. L., Schmoekel, H. G., Metters, A. T., Weber, F. E., Fields, G. B., & Hubbell, J. A. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0737381100 · Cited by 1,508
Rethinking ovarian cancer: recommendations for improving outcomes
Vaughan, S., Coward, J. I., Bast, R. C., Berchuck, A., Berek, J. S., Brenton, J. D., Coukos, G., Crum, C. C., Drapkin, R., Etemadmoghadam, D., et al. (2011) · Nature Reviews Cancer · doi:10.1038/nrc3144 · Cited by 1,464
Evaluating cell lines as tumour models by comparison of genomic profiles
Domcke, S., Sinha, R., Levine, D. A., Sander, C., & Schultz, N. (2013) · Nature Communications · doi:10.1038/ncomms3126 · Cited by 1,418
Ovarian cancer: strategies for overcoming resistance to chemotherapy
Agarwal, R., & Kaye, S. B. (2003) · Nature Reviews Cancer · doi:10.1038/nrc1123 · Cited by 1,154
Growth rate inhibition metrics correct for confounders in measuring sensitivity to cancer drugs
Hafner, M., Niepel, M., Chung, M., & Sorger, P. K. (2016) · Nature Methods · doi:10.1038/nmeth.3853 · Cited by 681
Loessner, D., Stok, K. S., Lutolf, M. P., Hutmacher, D. W., Clements, J. A., & Rizzi, S. C. (2010) · Biomaterials · doi:10.1016/j.biomaterials.2010.07.064 · Cited by 602
The Clinical Relevance of Cancer Cell Lines
Gillet, J.-P., Varma, S., & Gottesman, M. M. (2013) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djt007 · Cited by 599
Modeling tissue-specific signaling and organ function in three dimensions
Schmeichel, K. L., & Bissell, M. J. (2003) · Journal of Cell Science · doi:10.1242/jcs.00503 · Cited by 585
Meeting the challenge of ascites in ovarian cancer: new avenues for therapy and research
Kipps, E., Tan, D. S. P., & Kaye, S. B. (2013) · Nature Reviews Cancer · doi:10.1038/nrc3432 · Cited by 562
Phelps, E. A., Enemchukwu, N. O., Fiore, V. F., Sy, J. C., Murthy, N., Sulchek, T. A., Barker, T. H., & García, A. J. (2012) · Advanced Materials · doi:10.1002/adma.201103574 · Cited by 539
Tumor-derived spheroids: Relevance to cancer stem cells and clinical applications
Ishiguro, T., Ohata, H., Sato, A., Yamawaki, K., Enomoto, T., & Okamoto, K. (2017) · Cancer Science · doi:10.1111/cas.13155 · Cited by 530
Screening out irrelevant cell-based models of disease
Horvath, P., Aulner, N., Bickle, M., Davies, A. M., Nery, E. D., Ebner, D., Montoya, M. C., Östling, P., Pietiäinen, V., Price, L. S., et al. (2016) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2016.175 · Cited by 525
Mechanisms of transcoelomic metastasis in ovarian cancer
Tan, D. S., Agarwal, R., & Kaye, S. B. (2006) · The Lancet Oncology · doi:10.1016/s1470-2045(06)70939-1 · Cited by 520
Ahmed, N., & Stenvers, K. L. (2013) · Frontiers in Oncology · doi:10.3389/fonc.2013.00256 · Cited by 482
Multicellular spheroids in ovarian cancer metastases: Biology and pathology
Shield, K., Ackland, M. L., Ahmed, N., & Rice, G. E. (2009) · Gynecologic Oncology · doi:10.1016/j.ygyno.2008.11.032 · Cited by 412
Say no to DMSO: dimethylsulfoxide inactivates cisplatin, carboplatin, and other platinum complexes
Hall, M. D., Telma, K. A., Chang, K.-E., Lee, T. D., Madigan, J. P., Lloyd, J. R., Goldlust, I. S., Hoeschele, J. D., & Gottesman, M. M. (2014) · Cancer Research · doi:10.1158/0008-5472.can-14-0247 · Cited by 377
Functional precision cancer medicine—moving beyond pure genomics
Letai, A. (2017) · Nature Medicine · doi:10.1038/nm.4389 · Cited by 366
Xu, F., Celli, J., Rizvi, I., Moon, S., Hasan, T., & Demirci, U. (2011) · Biotechnology Journal · doi:10.1002/biot.201000340 · Cited by 337
Mesothelial Cells Promote Early Ovarian Cancer Metastasis through Fibronectin Secretion
Kenny, H. A., Chiang, C.-Y., White, E. A., Schryver, E. M., Habis, M., Romero, I. L., Ladanyi, A., Penicka, C. V., George, J., Matlin, K., et al. (2014) · Journal of Clinical Investigation · doi:10.1172/jci74778 · Cited by 303
LIFE ISN'T FLAT: TAKING CANCER BIOLOGY TO THE NEXT DIMENSION
SMALLEY, K. S. M., LIONI, M., & HERLYN, M. (2006) · In Vitro Cellular & Developmental Biology - Animal · doi:10.1290/0604027.1 · Cited by 302
Focus on epithelial ovarian cancer
Ozols, R. F., Bookman, M. A., Connolly, D. C., Daly, M. B., Godwin, A. K., Schilder, R. J., Xu, X., & Hamilton, T. C. (2004) · Cancer Cell · doi:10.1016/s1535-6108(04)00002-9 · Cited by 294
Alkhouli, N., Mansfield, J., Green, E., Bell, J., Knight, B., Liversedge, N., Tham, J. C., Welbourn, R., Shore, A. C., Kos, K., et al. (2013) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00111.2013 · Cited by 282
Tumor-Derived Cell Lines as Molecular Models of Cancer Pharmacogenomics
Goodspeed, A., Heiser, L. M., Gray, J. W., & Costello, J. C. (2016) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-15-0189 · Cited by 276
Defined three-dimensional microenvironments boost induction of pluripotency
Caiazzo, M., Okawa, Y., Ranga, A., Piersigilli, A., Tabata, Y., & Lutolf, M. P. (2016) · Nature Materials · doi:10.1038/nmat4536 · Cited by 271
Kenny, H. A., Krausz, T., Yamada, S. D., & Lengyel, E. (2007) · International Journal of Cancer · doi:10.1002/ijc.22874 · Cited by 243
Characterization of the Extracellular Matrix of Normal and Diseased Tissues Using Proteomics
Naba, A., Pearce, O. M. T., Del Rosario, A., Ma, D., Ding, H., Rajeeve, V., Cutillas, P. R., Balkwill, F. R., & Hynes, R. O. (2017) · Journal of Proteome Research · doi:10.1021/acs.jproteome.7b00191 · Cited by 228
Lee, J.-M., Nair, J., Zimmer, A., Lipkowitz, S., Annunziata, C. M., Merino, M. J., Swisher, E. M., Harrell, M. I., Trepel, J. B., Lee, M.-J., et al. (2018) · The Lancet Oncology · doi:10.1016/s1470-2045(18)30009-3 · Cited by 209
α11β1 Integrin Recognizes the GFOGER Sequence in Interstitial Collagens
Zhang, W.-M., Käpylä, J., Puranen, J. S., Knight, C. G., Tiger, C.-F., Pentikäinen, O. T., Johnson, M. S., Farndale, R. W., Heino, J., & Gullberg, D. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m210313200 · Cited by 179
Januchowski, R., Świerczewska, M., Sterzyńska, K., Wojtowicz, K., Nowicki, M., & Zabel, M. (2016) · Journal of Cancer · doi:10.7150/jca.15371 · Cited by 179
Sridhar, B. V., Brock, J. L., Silver, J. S., Leight, J. L., Randolph, M. A., & Anseth, K. S. (2015) · Advanced Healthcare Materials · doi:10.1002/adhm.201400695 · Cited by 175
Al Habyan, S., Kalos, C., Szymborski, J., & McCaffrey, L. (2018) · Oncogene · doi:10.1038/s41388-018-0317-x · Cited by 162
Puiffe, M.-L., Le Page, C., Filali-Mouhim, A., Zietarska, M., Ouellet, V., Tonin, P. N., Chevrette, M., Provencher, D. M., & Mes-Masson, A.-M. (2007) · Neoplasia · doi:10.1593/neo.07472 · Cited by 153
InVERT molding for scalable control of tissue microarchitecture
Stevens, K. R., Ungrin, M. D., Schwartz, R. E., Ng, S., Carvalho, B., Christine, K. S., Chaturvedi, R. R., Li, C. Y., Zandstra, P. W., Chen, C. S., et al. (2013) · Nature Communications · doi:10.1038/ncomms2853 · Cited by 137
Self-citationRaghavan, S., Ward, M. R., Rowley, K. R., Wold, R. M., Takayama, S., Buckanovich, R. J., & Mehta, G. (2015) · Gynecologic Oncology · doi:10.1016/j.ygyno.2015.04.014 · Cited by 136
Spatially Gradated Hydrogel Platform as a 3D Engineered Tumor Microenvironment
Pedron, S., Becka, E., & Harley, B. A. (2015) · Advanced Materials · doi:10.1002/adma.201404896 · Cited by 118
Gencoglu, M. F., Barney, L. E., Hall, C. L., Brooks, E. A., Schwartz, A. D., Corbett, D. C., Stevens, K. R., & Peyton, S. R. (2018) · ACS Biomaterials Science & Engineering · doi:10.1021/acsbiomaterials.7b00069 · Cited by 97
Self-citationContributions of 3D Cell Cultures for Cancer Research
Ravi, M., Ramesh, A., & Pattabhi, A. (2017) · Journal of Cellular Physiology · doi:10.1002/jcp.25664 · Cited by 88
Mabry, K. M., Schroeder, M. E., Payne, S. Z., & Anseth, K. S. (2016) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.5b11359 · Cited by 49
Liu, M., Zhang, X., Long, C., Xu, H., Cheng, X., Chang, J., Zhang, C., Zhang, C., & Wang, X. (2018) · RSC Advances · doi:10.1039/c7ra13742g · Cited by 48
Hafner, M. A., Heiser, L. M., Williams, E. H., Niepel, M., Wang, N. J., Korkola, J. E., Gray, J. W., & Sorger, P. K. (2017) · Scientific Data · doi:10.1038/sdata.2017.166 · Cited by 46
The significance of lumican expression in ovarian cancer drug-resistant cell lines
Klejewski, A., Sterzyńska, K., Wojtowicz, K., Świerczewska, M., Partyka, M., Brązert, M., Nowicki, M. O., Zabel, M., & Januchowski, R. (2017) · Oncotarget · doi:10.18632/oncotarget.20169 · Cited by 42
Epithelial ovarian cancer: Focus on targeted therapy
Pliarchopoulou, K., & Pectasides, D. G. (2010) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2010.07.004 · Cited by 33
Alberts, D. S., Einspahr, J. G., Struck, R. F., Bignami, G. S., Young, L., Surwit, E. A., & Salmon, S. E. (1984) · Investigational New Drugs · doi:10.1007/bf00232343 · Cited by 33
A High-Throughput Screening Model of the Tumor Microenvironment for Ovarian Cancer Cell Growth
Lal-Nag, M., McGee, L., Guha, R., Lengyel, E., Kenny, H. A., & Ferrer, M. (2017) · SLAS Discovery · doi:10.1177/2472555216687082 · Cited by 33
Complementary, Semiautomated Methods for Creating Multidimensional PEG-Based Biomaterials
Brooks, E. A., Jansen, L., Gencoglu, M. F., Yurkevicz, A. M., & Peyton, S. R. (2018) · ACS Biomaterials Science & Engineering · doi:10.1021/acsbiomaterials.7b00737 · Cited by 23
Self-citationLee, J., Karzai, F. H., Zimmer, A. S., Annunziata, C. M., Lipkowitz, S., PARKER, B. S., Houston, N. D., Ekwede, I., & Kohn, E. C. (2016) · Annals of Oncology · doi:10.1093/annonc/mdw374.02 · Cited by 18
Mueck, A. O., Seeger, H., Wallwiener, D. R., & Huober, J. (2004) · PubMed · Cited by 12
Research works printed but not linked: 3
- L. Jansen, T. McCarthy, M. Lee, and S. Peyton, preprint bioRxiv (2018).
- E. A. Brooks, S. Galarza, M. F. Gencoglu, R. C. Cornelison, J. M. Munson, and S. Peyton, preprint bioRxiv (2018).
- A. O. Mueck, H. Seeger, D. Wallwiener, and J. Huober, Eur. J. Gynaecol. Oncol. 25(6), 699– 701 (2004). 15597845
Cited by
The Untapped Potential of Ascites in Ovarian Cancer Research and Treatment
Ford, C. E., Werner, B., Hacker, N. F., & Warton, K. (2020) · British Journal of Cancer · doi:10.1038/s41416-020-0875-x · Cited by 261
Exploring the promising potential of induced pluripotent stem cells in cancer research and therapy
Chehelgerdi, M., Behdarvand Dehkordi, F., Chehelgerdi, M., Kabiri, H., Salehian-Dehkordi, H., Abdolvand, M., Salmanizadeh, S., Rashidi, M., Niazmand, A., Ahmadi, S., et al. (2023) · Molecular Cancer · doi:10.1186/s12943-023-01873-0 · Cited by 175
Recent advances on polymeric hydrogels as wound dressings
Pan, Z., Ye, H., & Wu, D. (2021) · APL Bioengineering · doi:10.1063/5.0038364 · Cited by 163
Mimicking tumor hypoxia and tumor-immune interactions employing three-dimensional in vitro models
Bhattacharya, S., Calar, K., & de la Puente, P. (2020) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-020-01583-1 · Cited by 99
Pradhan, S., & Slater, J. H. (2019) · Biomaterials · doi:10.1016/j.biomaterials.2019.04.022 · Cited by 84
Metadata
- Authors
- Brooks, E. A., Gencoglu, M. F., Corbett, D. C., Stevens, K. R., & Peyton, S. R.
- Affiliations
- University of Massachusetts Amherst (US)
- University of Washington (US)
- Corresponding author
- Peyton, Shelly R.
- Venue
- APL Bioengineering
- Publisher
- AIP Publishing
- Published
- 2019-06-01
- Volume
- 3
- Issue
- 2
- Pages
- 026106-026106
- ISSN
- 2473-2877 (ISSN-L)
- PMC
- PMC6594836
- OpenAlex
- W2954618703
- Cited by
- 51
- References
- 54
- Citations by year
- 2026: 1 · 2025: 9 · 2024: 3 · 2023: 4 · 2022: 12 · 2021: 8 · 2020: 11 · 2019: 3
- FWCI
- 3.00
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/4.0/ (vor, 25 d)
- creativecommons.org/licenses/by/4.0/ (tdm, 25 d)
- Locations
- APL Bioengineering (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Scholarly Commons (University of the Pacific) (submittedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
- ScholarWorks@UMassAmherst (University of Massachusetts Amherst) (submittedVersion, cc-by)
- Funders
- Barry and Afsaneh Siadat (Career Development Award)
- National Science Foundation (1454806)
- National Institutes of Health (1DP2CA186573-01, T32 GM008515)
- Pew Charitable Trusts (Research Scholar Award)
- Topics
- Physical Sciences › Engineering › Biomedical Engineering › 3D Printing in Biomedical Research
- Physical Sciences › Materials Science › Biomaterials › Hydrogels: synthesis, properties, applications
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Cellular Mechanics and Interactions
- Keywords
- ovarian cancer, drug resistance, paclitaxel resistance, poly(ethylene glycol) hydrogels, microwells, extracellular matrix, type III collagen, SKOV3 cells, in vitro drug testing, collagen synthesis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.